121 related articles for article (PubMed ID: 16525683)
1. Optimal combination chemotherapy and chemoradiotherapy with etoposide for advanced cervical squamous cancer cells in vitro.
Tanaka T; Bai T; Yukawa K; Umesaki N
Oncol Rep; 2006 Apr; 15(4):939-47. PubMed ID: 16525683
[TBL] [Abstract][Full Text] [Related]
2. Reduced radiosensitivity and increased CD40 expression in cyclophosphamide-resistant subclones established from human cervical squamous cell carcinoma cells.
Tanaka T; Bai T; Yukawa K; Utsunomiya T; Umesaki N
Oncol Rep; 2005 Oct; 14(4):941-8. PubMed ID: 16142355
[TBL] [Abstract][Full Text] [Related]
3. Combination effects of irradiation and irinotecan on cervical squamous cell carcinoma cells in vitro.
Tanaka T; Yukawa K; Umesaki N
Oncol Rep; 2005 Nov; 14(5):1365-9. PubMed ID: 16211310
[TBL] [Abstract][Full Text] [Related]
4. Radiation reduces pirarubicin sensitivity in human cervical squamous cell carcinoma cells.
Tanaka T; Umesaki N
Oncol Rep; 2005 Jun; 13(6):1165-8. PubMed ID: 15870938
[TBL] [Abstract][Full Text] [Related]
5. Effective chemoradiotherapy protocol with 5-fluorouracil for cervical squamous cell carcinoma in vitro.
Tanaka T; Yukawa K; Umesaki N
Eur J Gynaecol Oncol; 2006; 27(3):243-6. PubMed ID: 16800250
[TBL] [Abstract][Full Text] [Related]
6. Demethylation restores SN38 sensitivity in cells with acquired resistance to SN38 derived from human cervical squamous cancer cells.
Tanaka T; Bai T; Toujima S; Utsunomiya T; Matsuoka T; Kobayashi A; Yamamoto M; Sasaki N; Tanizaki Y; Utsunomiya H; Tanaka J; Yukawa K
Oncol Rep; 2012 Apr; 27(4):1292-8. PubMed ID: 22246465
[TBL] [Abstract][Full Text] [Related]
7. Effects of mitomycin C on radiation-induced cell death in human cervical squamous cell carcinomas.
Tanaka T; Umesaki N
Eur J Gynaecol Oncol; 2005; 26(4):411-4. PubMed ID: 16122190
[TBL] [Abstract][Full Text] [Related]
8. Radiation enhances cisplatin-sensitivity in human cervical squamous cancer cells in vitro.
Tanaka T; Yukawa K; Umesaki N
Eur J Gynaecol Oncol; 2005; 26(4):431-3. PubMed ID: 16122195
[TBL] [Abstract][Full Text] [Related]
9. Radiation reduces carboplatin sensitivity and enhances nedaplatin sensitivity in cervical squamous cell carcinoma in vitro.
Tanaka T; Yukawa K; Umesaki N
Eur J Gynaecol Oncol; 2007; 28(5):352-5. PubMed ID: 17966212
[TBL] [Abstract][Full Text] [Related]
10. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
[TBL] [Abstract][Full Text] [Related]
11. Clonal analysis of cancer cells that survived anticancer drug treatment.
Tanaka T; Chang L; Umesaki N; Ogita S
Osaka City Med J; 1997 Dec; 43(2):259-65. PubMed ID: 9540347
[TBL] [Abstract][Full Text] [Related]
12. Radiation-induced cell death is independent of the apoptotic signals mediated by death-associated protein kinase in human cervical squamous cell carcinoma cells.
Tanaka T; Bai T; Yukawa K; Umesaki N
Oncol Rep; 2005 Oct; 14(4):949-55. PubMed ID: 16142356
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity to topoisomerase I inhibitors and cisplatin is associated with epidermal growth factor receptor expression in human cervical squamous carcinoma ME180 sublines.
Ling YH; Donato NJ; Perez-Soler R
Cancer Chemother Pharmacol; 2001 Jun; 47(6):473-80. PubMed ID: 11459199
[TBL] [Abstract][Full Text] [Related]
14. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
[TBL] [Abstract][Full Text] [Related]
15. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells.
Bai T; Tanaka T; Yukawa K; Umesaki N
Int J Oncol; 2006 Feb; 28(2):497-508. PubMed ID: 16391806
[TBL] [Abstract][Full Text] [Related]
16. Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs.
Xie L; Song X; Yu J; Wei L; Song B; Wang X; Lv L
J Exp Clin Cancer Res; 2009 May; 28(1):68. PubMed ID: 19470182
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
[TBL] [Abstract][Full Text] [Related]
18. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
Zhang MQ; Liu SP; Wang XE
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
[TBL] [Abstract][Full Text] [Related]
19. Differential sensitivity to paclitaxel-induced apoptosis and growth suppression in paclitaxel-resistant cell lines established from HEC-1 human endometrial adenocarcinoma cells.
Tanaka T; Toujima S; Tanaka J
Int J Oncol; 2012 Nov; 41(5):1837-44. PubMed ID: 22923148
[TBL] [Abstract][Full Text] [Related]
20. Cellular response to chemotherapy and radiation in cervical cancer.
Saxena A; Yashar C; Taylor DD; Gercel-Taylor C
Am J Obstet Gynecol; 2005 May; 192(5):1399-403. PubMed ID: 15902120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
